🇺🇸 Calcipotriol plus betamethasone in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 5

Most-reported reactions

1. Abdominal Pain — 1 report (20%)
2. Cholecystitis — 1 report (20%)
3. Hepatic Cyst — 1 report (20%)
4. Nausea — 1 report (20%)
5. Pleural Effusion — 1 report (20%)

Source database →

Frequently asked questions

Is Calcipotriol plus betamethasone approved in United States?

Calcipotriol plus betamethasone does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Calcipotriol plus betamethasone in United States?

LEO Pharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.